Health News | Research: Genetic Clues Link Lipoprotein A to Prostate Cancer Risk | LatestLY
Lipoprotein(a) and prostate cancer risk? Another reason to check it
Related Articles
Communication and sexual function and frequency in breast cancer patients 2 years after diagnosis: results from the VICAN 2 study
AbstractBackground. Breast cancer treatments may have impacts on several aspects of sexual health, including psychological, psychosexual, physiological, ph
Assembly Members to Unite in San Diego – ATSConferenceNews.org
The 14 Assemblies of the ATS will hold membership meetings in San Diego on Sunday, May 19, and Monday, May 20, during the International Conference.…
Alzheimer’s: Newly found genetic variant may lower risk by 71%
In a recent study, researchers suggest that a newly identified genetic variant may protect against Alzheimer’s disease, reducing the risk of developing this condition by…
FDA Update: Heartmate II and Heartmate 3 LVAS Recalled Due to Obstruction – American College of Cardiology
The U.S. Food and Drug Administration (FDA) announced on April 15 that Abbott/Thoratec Corp. is recalling the Heartmate II and Heartmate 3 Left Ventricular Assist…
Behavioral health provider Two Chairs clinches $72M in equity, debt to expand hybrid model
Two Chairs, a hybrid behavioral health provider, has closed $72 million in a series C equity and debt financing round. | The company operates in…
Boston Dynamics’ Atlas humanoid robot goes electric | TechCrunch
Atlas lies motionless in a prone position atop interlocking gym mats. The only soundtrack is the whirring of an electric motor. It’s not quiet, exactly,
ICCV 2023 top papers, general trends, and personal picks | AI Summer
Do you want to learn all the latest state-of-the-art methods of the last year? Learn about the best and most famous papers that made the…
Google is combining its Android and hardware teams — and it’s all about AI
Pixel, Android, Chrome, and ChromeOS are now all one big AI-friendly family.
Novel Parkinson’s Disease Drug Will Join AbbVie With Positive Phase 3 Data In Hand – MedCity News
Cerevel Therapeutics drug tavapadon met the main and secondary goals of a pivotal Parkinson’s disease clinical trial. That drug and others will join the neuroscience…
